OR WAIT 15 SECS
Eli Lilly was awarded the 2017 FOYA Overall Winner for its continuous direct compression manufacturing installation projects.
The International Society for Pharmaceutical Engineering (ISPE) announced Eli Lilly and Company as the Overall Winner of the 2017 Facility of the Year Awards (FOYA) program on Oct. 31, 2017 at ISPE’s Annual Meeting & Expo in San Diego, California. Eli Lilly was awarded for their Continuous Direct Compression Manufacturing Kits 2 & 3 project in Indianapolis, Indiana and Carolina, Puerto Rico.
The company’s primary goal for the project was to quickly build a network of GMP oral solid dosage (OSD) facilities to deliver new advanced therapies to patients. Each of the three OSD installations were built sequentially in existing operating facilities at three separate geographic sites. Replicated facilities reduce technical transfer time from development to commercial manufacturing, as well as compress the schedule and create budget efficiencies. As a result, the delivery schedule for each subsequent project continued to improve from the baseline case, and millions of dollars were saved from replication and learning, according to the ISPE press release.
This combination of technology and process understanding, along with identical standardized production platforms, is what made this project the Facility of the Year Awards Overall Winner, according to the press release. The company was also the winner of the 2017 Facility of the Future and the Process Innovation category awards, announced in February 2017.
Related Content:Bio/Pharma News | Solid/Semi-Solid Dosage | PharmTech News | Manufacturing | Scale Up | Facility Design and Engineering | Development | Dosage Forms | Technology Transfer | Manufacturing, Solid Dosage Drugs | Manufacturing, Drug Products | Manufacturing, Continuous Solid Dosage Processing